In this study, chitosan-alginate polyelectrolyte microparticles containing the antibiotic, vancomycin chloride were prepared using the ionotropic gelation (coacervation) technique. In vitro release and drug transport mechanisms were studied concerning the chitosan only and alginate only microparticles as a control group. Further, the effect of porosity on the drug transport mechanism was also studied for chitosan-alginate mixed particles produced by lyophilizing in contrast to the air-dried non-porous particles. According to the in vitro release data, alginate only and chitosan only microparticles showed burst release and prolonged release respectively. Chitosan-alginate lyophilized microparticles showed the best-controlled release of vancomycin with the average release of 22μg per day for 14days. Also, when increasing alginate concentration there was no increase in the release rate of vancomycin. The release data of all the microparticles were treated with Ritger-Peppas, Higuchi, Peppas-Sahlin, zero-order, and first-order kinetic models. The best fit was observed with Peppas-Sahlin model, indicating the drug transport mechanism was controlled by both Fickian diffusion and case II relaxations. Also, Fickian diffusion dominates the drug transport mechanism of all air-dried samples during the study period. However, the Fickian contribution was gradually reducing with time. Porosity significantly effects the drug transport mechanism as case II relaxation dominates after day 10 of the lyophilized microparticles.
Curcumin-loaded ZnO nanocomposites act as an effective, synergistically-enhanced combination delivery/therapeutic agent, holding promise for anticancer and antimicrobial therapy with reduced toxicities.
Chitosan microparticles were mixed with chitosan and carboxymethyl cellulose solution to achieve a good binding between the microparticles. Three different compositions of scaffolds were made by varying the calcium phosphate (CaP) amount: 0%, 10%, and 20%. Potassium chloride was used as salt, to make pores inside the scaffolds after leaching out when immersed in phosphate buffer saline (PBS). Compressive strength and compressive modulus of both non-porous (before leaching out), and porous (after leaching out) scaffolds were measured according to the ASTM standards. The highest compressive strength of 27 MPa was reported on 10% CaP scaffolds while 20% CaP scaffolds showed the lowest. The increasing CaP content reduces the compressive strength of the scaffolds. The highest wet state compressive strength was reported on 0% CaP scaffolds with 0.36 MPs and 0.40 MPa at day 1 and day 3 respectively. In vitro cell culture studies showed good cell adhesion and cell proliferation on 10% CaP scaffolds.
Bone
morphogenetic protein-9 (BMP-9) has been shown to be the most
osteogenic BMP. Most of these experiments, however, involve an adenovirus-transfection
strategy. Here, we used the scaffold-based strategy to study the bone
forming ability of recombinant BMP-9 combined with vascular endothelial
growth factor (VEGF). A robust, injectable, multicomponent-releasing
scaffold in the form of a composite gel was developed by combining
chitosan microparticles (MPs) with thermosensitive gel (MPs-gel).
The MPs acted as the carriers for BMP-9 and the gel was loaded with
VEGF. The developed gel consisted of hydrophobic chains of methyl
cellulose (MC) and the cross-linked structures of alginate (Alg) and
calcium. Gelation was achieved at physiological temperature and thus
facilitated the injection and localization of MPs enabling an increased
efficacy of incorporated growth factors at the target site. A release
profile of incorporated growth factors over a two-week period showed
higher release of VEGF at each time point compared to that of BMP-9.
Human mesenchymal stem cells (hMSCs) encapsulated within the MPs-gel
maintained their viability. BMP-9 enhanced the proliferation of hMSCs
along the surface of MPs. Furthermore, BMP-9 potently induced the
osteogenic differentiation of encapsulated hMSCs elucidated by the
increased alkaline phosphatase (ALP) activity and the higher expression
of ALP, collagen 1, and osteocalcin genes. In addition, in
vivo experiments demonstrated that MPs-gel with the combination
of BMP-9-VEGF could significantly enhance both subcutaneous and cranial
bone formation (p < 0.05). Taken together, the
results here strongly suggest that BMP-9-VEGF incorporated MPs-gel
holds promise as an injectable bone tissue engineering platform.
Zinc oxide-cloxacillin incorporated nanoparticles coated with concentric layers of polycaprolactone and albumin via a coaxial electrospraying technique as an enhanced and sustained antimicrobial delivery system for respiratory infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.